The data, reported in part last month but published in full in The
Lancet medical journal on Thursday, suggest that those aged over 70 -
who are at higher risk of serious illness and death from COVID-19 -
could build robust immunity to the pandemic disease, researchers said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-covid-19-shot-candidate-shows-promise-among-elderly-in-trials/articleshow/79299148.cms
No comments:
Post a Comment